Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production ...

Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central ...

In today’s ACT Brief, we explore how Eli Lilly’s orforglipron could become the first oral GLP-1 therapy reviewed under FDA’s new national priority program, and examine emerging regulatory and ethical ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the quarter.

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are ...

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

Or how about the drug companies? Holy cow, remember them? They used to be big and important, weren’t they? Eli Lilly reported this morning, and their GLP-1 complex, you know, the weight loss ...

Discover how the Magnificent 7 stocks and artificial intelligence demand fueled a record S&P 500 earnings surge in Q3 2025, ...

The AI chip darling already has the most cutting-edge products and the best customers. The next thing to do is to find more of them.

The rise of artificial intelligence is not only affecting how people work—it’s also shaping the job market itself, especially ...

GPU semiconductor factory, Jensen Huang’s roadmap connects data centers, networks, and industrial systems into a ...

Healthcare stocks in the S&P 500 are up just 4.8% for the year, compared to the S&P 500's 15.9% gain.